Key points are not available for this paper at this time.
These findings suggest that SII could serve as a useful, noninvasive marker for diagnosing and monitoring MAFLD, warranting further longitudinal studies to explore its role in disease progression and treatment response.
Kösekli et al. (Sat,) studied this question.